On March 27, 2018, Christopher Dean resigned his positions as an officer and director of Frélii, Inc. to focus his efforts on developing new technologies for the Company in his role as lead programmer. Mr. Dean was appointed to the Company's Board of Directors and as Chief Technology Officer on January 17, 2018. On March 27, 2018, Dr. Hans Jenkins was appointed to the Company's Board of Directors and as Chief Medical Officer of the Company. Dr. Jenkins is currently employed as a family medicine physician at MountainStar Medical Group in Farmington, Utah, and is also Medical Director and Managing Member of Orn Industries, LLC. On March 27, 2018, Julia Kline was appointed Secretary of the Company. Ms. Kline has served as the Company's Chief Operating Officer and General Counsel since January 17, 2018.
Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâs site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.
FRÉLII, INC. 
